Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Daly

Showing results (291-300 of 397) with videos related to

Pageof 40
Sort By:
The Pharmacogenomics Journal|February 7, 2020
HLA associations with infliximab-induced liver injuryChristopher D Bruno, Brandon Fremd, Rachel J Church, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathwaysCatherine Potter, Heather J Cordell, Anne Barton, et al.
Blood|June 11, 2005
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenElizabeth A Sconce, Tayyaba I Khan, Hilary A Wynne, et al.
Pharmacogenetics|February 18, 1999
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2012
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastomaGareth J Veal, Julie Errington, Sophie E Rowbotham, et al.
Blood|March 1, 1987
Durability of responses to interferon alfa-2b in advanced hairy cell leukemiaM J Ratain, H M Golomb, R G Bardawil, et al.
Diabetes Care|December 3, 2015
Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 DiabetesSarah Steven, Kieren G Hollingsworth, Peter K Small, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humansB D Livingston, J Alexander, C Crimi, et al.
Journal of Hepatology|March 6, 1999
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosisD E Jones, F E Watt, J Grove, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver diseaseMatteo Vidali, Stephen F Stewart, Roberta Rolla, et al.
Pageof 40

Showing results (291-300 of 397) with videos related to

Sort By:
Pageof 40
The Pharmacogenomics Journal|February 7, 2020
HLA associations with infliximab-induced liver injuryChristopher D Bruno, Brandon Fremd, Rachel J Church, et al.
Annals of the Rheumatic Diseases|May 8, 2010
Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathwaysCatherine Potter, Heather J Cordell, Anne Barton, et al.
Blood|June 11, 2005
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimenElizabeth A Sconce, Tayyaba I Khan, Hilary A Wynne, et al.
Pharmacogenetics|February 18, 1999
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in CaucasiansG C Ibeanu, J Blaisdell, B I Ghanayem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2012
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastomaGareth J Veal, Julie Errington, Sophie E Rowbotham, et al.
Blood|March 1, 1987
Durability of responses to interferon alfa-2b in advanced hairy cell leukemiaM J Ratain, H M Golomb, R G Bardawil, et al.
Diabetes Care|December 3, 2015
Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 DiabetesSarah Steven, Kieren G Hollingsworth, Peter K Small, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 1999
Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humansB D Livingston, J Alexander, C Crimi, et al.
Journal of Hepatology|March 6, 1999
Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosisD E Jones, F E Watt, J Grove, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver diseaseMatteo Vidali, Stephen F Stewart, Roberta Rolla, et al.
Pageof 40